A blog about chemistry, drug development, science, and technology
The US isn’t the only country that is trying to decide what to do in regard to drug pricing.
British regulator calls for drug pricing overhaul - International Herald Tribune
The Office of Fair Trade in Britain wants to change a 50 year old law that places profit limits on branded prescription drugs. They state it could save the country almost $1 billion each year. The proposed plan would tie pricing to the therapeutic benefit they provide to patients but details of how this would be determined were not mentioned.
Other countries have instituted a similar program and include Australia, Canada, and Sweden.The drub manufacturers in Britain such as GlaxoSmithKline and AstraZeneca are concerned about delays relating to launch as well as discourage future companies from investing in the pharmaceutical industry in Britain.
Technorati Tags: drug cost, drug price
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.987 seconds